Partner Content Partner Content Pfizer presents the opening keynote at the SMi’s ADC Confere... ADC Summit 2018
News Avacta hoping to disrupt antibody drug dominance Avacta is one of several biotechs turning their backs on mabs.
News Sobi adds rare lymphoma drug with $580m Innate tie-up Sobi chief executive Guido Oelkers is preparing his exit, but is still cutting deals, licensing a lymphoma drug from Innate for up to $580m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
